Advertisement

Buy track record

How this insider's open-market purchases have performed
8%
of buys now in profit
1 up · 12 down
Avg return since buy−92.1%
Median return−100.0%
Best trade+1.7%
Worst trade−100.0%
Buys scored13
Average return by holding period — separates good entry timing from riding one long winner
After 1 month +1.0% 8% won · 13 trades
After 3 months −0.1% 0% won · 13 trades
After 6 months +0.0% 0% won · 12 trades
After 12 months +0.0% 0% won · 12 trades
DateCompany90d trendBuy priceValueΔOwn1M3M6M12MTo date
Mar 2, 2026 GENB $16 $25M NEW +13.0% −1.6% +1.7%
Jan 30, 2013 BGMD $2 $500K +11% +0.0% +0.0% +0.0% +0.0% −100.0%
Jan 30, 2013 BGMD $2 $250K +24% +0.0% +0.0% +0.0% +0.0% −100.0%
Jan 30, 2013 BGMD $2 $150K +54% +0.0% +0.0% +0.0% +0.0% −100.0%
Jan 30, 2013 BGMD $2 $1M +21% +0.0% +0.0% +0.0% +0.0% −100.0%
Jan 30, 2013 BGMD $2 $2.1M +147% +0.0% +0.0% +0.0% +0.0% −100.0%
Feb 9, 2011 BGMD $7 $250K +7.3% +0.0% +0.0% +0.0% +0.0% −100.0%
Feb 9, 2011 BGMD $7 $75K +3.7% +0.0% +0.0% +0.0% +0.0% −100.0%
Feb 9, 2011 BGMD $7 $150K +30% +0.0% +0.0% +0.0% +0.0% −100.0%
Feb 9, 2011 BGMD $7 $100K +11% +0.0% +0.0% +0.0% +0.0% −100.0%
Feb 9, 2011 BGMD $7 $1.9M +13% +0.0% +0.0% +0.0% +0.0% −100.0%
Feb 9, 2011 BGMD $7 $300K +2.0% +0.0% +0.0% +0.0% +0.0% −100.0%
Feb 9, 2011 BGMD $7 $5M NEW +0.0% +0.0% +0.0% +0.0% −100.0%
How this is calculated. We score only open-market purchases (SEC code P) — the buys that carry real signal. Each trade's return is measured from the adjusted closing price on the purchase date to the latest close, accounting for stock splits and dividends. The 1M/3M/6M/12M columns show the same trade's return after each fixed holding period; a dash means that horizon hasn't elapsed yet or isn't priceable. Sales are excluded because insiders sell for many routine reasons. With only 13 scored trades, treat this as a small sample, not a verdict.
Advertisement
Open-market buys
$36.78M
13 trades
Open-market sells
$106.91M
166 trades
Net flow
−$70.14M
Net selling
Total filings
183
transactions shown

Full transaction history

All Form 4 activity across every company, newest first
View on SEC EDGAR ↗
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed May 17, 2024 ΔOwn −0.1%

Afeyan Noubar sold $332K of MRNA.

−$332K
2,600 sh @ $128
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed May 17, 2024 ΔOwn −0.3%

Afeyan Noubar sold $735.3K of MRNA.

−$735.3K
5,711 sh @ $129
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed May 17, 2024

Afeyan Noubar sold $25.8K of MRNA.

−$25.8K
200 sh @ $129
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed May 10, 2024 ΔOwn −0.1%

Afeyan Noubar sold $240.7K of MRNA.

−$240.7K
2,000 sh @ $120
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed May 10, 2024 ΔOwn −0.2%

Afeyan Noubar sold $608.4K of MRNA.

−$608.4K
5,004 sh @ $122
Advertisement
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed May 10, 2024 ΔOwn −0.4%

Afeyan Noubar sold $976.1K of MRNA.

−$976.1K
7,996 sh @ $122
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed May 3, 2024 ΔOwn −0.2%

Afeyan Noubar sold $436.8K of MRNA.

−$436.8K
3,982 sh @ $110
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed May 3, 2024 ΔOwn −0.2%

Afeyan Noubar sold $504.9K of MRNA.

−$504.9K
4,572 sh @ $110
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed May 3, 2024 ΔOwn −0.2%

Afeyan Noubar sold $473.6K of MRNA.

−$473.6K
4,246 sh @ $112
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed May 3, 2024 ΔOwn −0.1%

Afeyan Noubar sold $169.2K of MRNA.

−$169.2K
1,500 sh @ $113
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed May 3, 2024

Afeyan Noubar sold $79.4K of MRNA.

−$79.4K
700 sh @ $113
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Apr 26, 2024 ΔOwn −0.2%

Afeyan Noubar sold $420.7K of MRNA.

−$420.7K
3,926 sh @ $107
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Apr 26, 2024 ΔOwn −0.3%

Afeyan Noubar sold $630.4K of MRNA.

−$630.4K
5,821 sh @ $108
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Apr 26, 2024 ΔOwn −0.2%

Afeyan Noubar sold $452.8K of MRNA.

−$452.8K
4,153 sh @ $109
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Apr 26, 2024 ΔOwn −0.1%

Afeyan Noubar sold $120.9K of MRNA.

−$120.9K
1,100 sh @ $110
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Apr 19, 2024 ΔOwn −0.4%

Afeyan Noubar sold $849.8K of MRNA.

−$849.8K
8,243 sh @ $103
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Apr 19, 2024 ΔOwn −0.3%

Afeyan Noubar sold $671.4K of MRNA.

−$671.4K
6,475 sh @ $104
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Apr 19, 2024

Afeyan Noubar sold $29.5K of MRNA.

−$29.5K
282 sh @ $104
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Apr 12, 2024 ΔOwn −0.3%

Afeyan Noubar sold $677K of MRNA.

−$677K
6,351 sh @ $107
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Apr 12, 2024 ΔOwn −0.4%

Afeyan Noubar sold $806.1K of MRNA.

−$806.1K
7,512 sh @ $107
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Apr 12, 2024

Afeyan Noubar sold $81.2K of MRNA.

−$81.2K
748 sh @ $109
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Apr 12, 2024

Afeyan Noubar sold $42.5K of MRNA.

−$42.5K
389 sh @ $109
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Apr 5, 2024

Afeyan Noubar sold $19.5K of MRNA.

−$19.5K
200 sh @ $97
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Apr 5, 2024 ΔOwn −0.1%

Afeyan Noubar sold $149K of MRNA.

−$149K
1,499 sh @ $99
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Apr 5, 2024 ΔOwn −0.2%

Afeyan Noubar sold $318.8K of MRNA.

−$318.8K
3,167 sh @ $101
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Apr 5, 2024 ΔOwn −0.2%

Afeyan Noubar sold $388.3K of MRNA.

−$388.3K
3,832 sh @ $101
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Apr 5, 2024 ΔOwn −0.2%

Afeyan Noubar sold $359.3K of MRNA.

−$359.3K
3,500 sh @ $103
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Apr 5, 2024 ΔOwn −0.1%

Afeyan Noubar sold $280K of MRNA.

−$280K
2,702 sh @ $104
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Apr 5, 2024

Afeyan Noubar sold $10.4K of MRNA.

−$10.4K
100 sh @ $104
MRNA
Sell AFEYAN NOUBAR · Director · Open-market sale · filed Mar 29, 2024 ΔOwn −0.1%

Afeyan Noubar sold $192.1K of MRNA.

−$192.1K
1,817 sh @ $106

Frequently asked questions

How is AFEYAN NOUBAR's win rate calculated?

We take every open-market purchase (SEC code P) we can match to a stock price, then compare the split- and dividend-adjusted price on the purchase date to the most recent close. The win rate is the share of those buys currently trading above the purchase price. Sales and share grants are not scored.

Why are some buys not included in the score?

A purchase is excluded if we can't price it — for example if the ticker is missing from the filing, the company has been delisted, or the security isn't a common stock we can match to market data. Excluded counts are shown next to the scored total.

What do the 1M / 3M / 6M / 12M columns mean?

They show each purchase's return after a fixed holding period — one, three, six, and twelve months from the buy date — using split- and dividend-adjusted prices. This separates good entry timing from simply holding a long-running winner. A dash means that horizon hasn't elapsed yet for that trade, or the stock couldn't be priced at that date.

Does a high win rate mean I should copy this insider?

No. Past performance does not predict future results, sample sizes are often small, and an insider's edge in their own company doesn't transfer to yours. This is context, not a recommendation. InsiderSource is not investment advice.

Where does this data come from?

Trades come from AFEYAN NOUBAR's SEC Form 4 filings on EDGAR. Prices come from public market data and are split/dividend-adjusted. Always verify against the original filings before acting.